Recombinant SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta) Protein
The Recombinant SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta) Protein represents a critical molecular component of the SARS-CoV-2 virus, playing an essential role in viral entry and host cell infection mechanisms. This protein is extensively utilized in COVID-19 research, vaccine development, therapeutic antibody screening, and diagnostic assay development, serving as a fundamental tool for understanding viral pathogenesis and developing countermeasures against coronavirus infections.
This product (SKU: RPCB1585) is produced using HEK293 cells and features a C-His&Avi tag for convenient detection and purification. The protein exhibits a calculated molecular weight of 48.11 kDa with an observed molecular weight of 50-55 kDa under denaturing conditions, achieving ≥ 95 % as determined by SDS-PAGE., ensuring exceptional quality and consistency for research applications.
Key Features
High Purity by Affinity Chromatography
Mammalian & Bacterial Expression Systems
High lot-to-lot consistency via strict QC
Product Name:
Recombinant SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta) Protein
High quality, high purity and low endotoxin recombinant Recombinant SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta) Protein (RP01509LQ), tested reactivity in E. coli and has been validated in SDS-PAGE.100% guaranteed.
Endotoxin:
< 0.1 EU/μg of the protein by LAL method.
Purity:
≥ 95 % as determined by SDS-PAGE.
Formulation:
Supplied as a 0.22 μm filtered solution in 20 mM Tris,150 mM NaCl,10% glycerol,pH8.0.
Storage:
Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.
Recombinant SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta) Protein was determined by SDS-PAGE under reducing conditions with Coomassie Blue.
